What Does Levonorgestrel Deplete? 7 Nutrients Affected
Taking this medication? Check what it depletesFree, 10 seconds →
Depletions Overview
Vitamin B6
ModerateLevonorgestrel accelerates tryptophan metabolism through the kynurenine pathway, consuming pyridoxal phosphate (the active form of B6) as a cofactor at dramatically increased rates. According to 223 gene interactions cataloged in CTD for levonorgestrel, estrogen-responsive tryptophan dioxygenase upregulation creates a metabolic drain on B6 reserves that worsens with duration of use. This B6 depletion is clinically significant because pyridoxal phosphate is also the rate-limiting cofactor for serotonin and dopamine synthesis — meaning the mood changes many women attribute to their hormonal contraceptive may actually reflect a correctable nutrient deficiency.
Folate
ModerateLevonorgestrel impairs folate polyglutamate absorption in the intestinal brush border and accelerates hepatic folate catabolism through progesterone receptor-mediated enzyme induction. Across 1,527 PubMed-indexed articles on levonorgestrel, the folate-lowering effect of hormonal contraceptives is among the most consistently documented nutrient interactions. This is especially consequential for women of reproductive age because folate is critical for neural tube development in the first 28 days of pregnancy — often before a woman realizes she has conceived. Discontinuing levonorgestrel without prior folate repletion creates a high-risk window.
Vitamin B12
LowLevonorgestrel reduces vitamin B12 absorption by altering intrinsic factor binding and lowering transcobalamin II transport protein levels. According to ChEMBL mechanism-of-action data classifying levonorgestrel as a progesterone receptor agonist, the hormonal shift toward a progesterone-dominant state modifies gastric acid secretion and mucosal protein expression in ways that impair B12 uptake from food. Depletion develops slowly because the liver stores 3-5 years of B12, but subclinical deficiency — detectable by elevated methylmalonic acid before serum B12 drops below range — can accumulate in long-term users.
Magnesium
Low-ModerateLevonorgestrel increases renal magnesium excretion through progesterone-mediated changes in kidney tubular reabsorption. Across 109 randomized controlled trials involving 269,064 patients in levonorgestrel research indexed by CTD, the progesterone receptor activation shifts electrolyte handling toward sodium and water retention at the expense of magnesium conservation. This mirrors the magnesium loss seen in the luteal phase of natural menstrual cycles but occurs continuously rather than cyclically. Low magnesium compounds mood symptoms and sleep disturbance already associated with hormonal contraceptive use.
Zinc
Low-ModerateLevonorgestrel redistributes zinc from serum into hepatic metallothionein storage, lowering circulating bioavailable zinc while simultaneously increasing copper levels. According to 68 curated disease associations for levonorgestrel in CTD, this zinc-copper imbalance is a recognized endocrine disruptor effect of progestins. Elevated copper-to-zinc ratio has been independently associated with mood disturbance, anxiety, and hormonal sensitivity. Zinc is also essential for immune function, wound healing, and thyroid hormone conversion — areas where levonorgestrel users may notice subtle functional decline.
Vitamin C
LowLevonorgestrel increases oxidative stress through progesterone-mediated metabolic shifts, accelerating vitamin C consumption as an antioxidant defense. Across 1,715 disease associations in CTD for levonorgestrel, the oxidative burden of continuous hormonal exposure depletes ascorbic acid reserves that protect blood vessels, support collagen synthesis, and enhance iron absorption. This depletion develops gradually and compounds with other antioxidant losses (vitamin E), creating cumulative oxidative vulnerability in long-term users.
Vitamin E
LowLevonorgestrel increases hepatic vitamin E catabolism through CYP-mediated oxidation pathways. As the primary fat-soluble antioxidant, vitamin E is consumed at increased rates when progesterone receptor activation elevates lipid peroxidation throughout cell membranes. According to 223 gene interactions for levonorgestrel in CTD, antioxidant defense gene networks are significantly represented. The combined depletion of vitamins C and E reduces total antioxidant capacity, potentially contributing to the vascular endothelial dysfunction that underlies the small but measurable increase in thrombotic risk associated with hormonal contraceptives.
Wondering about YOUR specific medications?
Check free — no signup, 10 seconds →How It Causes Depletions
Levonorgestrel is a synthetic progestin prescribed across multiple delivery systems — the Mirena and Kyleena intrauterine devices, Plan B emergency contraception, and combined oral contraceptive pills — reaching approximately 2 million Mirena IUD insertions annually in the United States alone, plus substantial oral contraceptive market share. According to ChEMBL mechanism-of-action data, levonorgestrel functions as a progesterone receptor agonist that suppresses ovulation, thickens cervical mucus, and thins the endometrial lining. With 100% oral bioavailability, 98.25% protein binding, a 40-hour elimination half-life, and peak plasma concentration at 60 hours for IUD formulations, levonorgestrel delivers sustained hormonal exposure that profoundly alters metabolic enzyme activity across B-vitamin, mineral, and antioxidant pathways. The 7 nutrient depletions are not incidental side effects but direct downstream consequences of progesterone receptor activation across 223 gene interactions cataloged in CTD.
The Comparative Toxicogenomics Database documents 1,715 disease associations and 68 curated disease links for levonorgestrel, reflecting the breadth of metabolic disruption from continuous synthetic progestin exposure. Vitamin B6 depletion is the most clinically impactful because pyridoxal phosphate is the rate-limiting cofactor for serotonin and dopamine synthesis — the neurotransmitters most directly responsible for mood, motivation, and emotional resilience. Folate depletion carries unique reproductive urgency: women discontinuing levonorgestrel to conceive face a critical window where depleted folate stores must be repleted before conception to prevent neural tube defects. Across 1,527 PubMed-indexed articles on levonorgestrel, the B6-folate-B12 triad depletion creates overlapping methylation pathway impairment that elevates homocysteine, a cardiovascular risk marker that compounds the small baseline thrombotic risk already associated with hormonal contraceptives.
Magnesium and zinc depletions operate through electrolyte and metallothionein redistribution pathways. Levonorgestrel shifts renal magnesium handling and hepatic zinc sequestration in ways that lower circulating bioavailable levels of both minerals. Across 109 randomized controlled trials involving 269,064 patients in levonorgestrel research indexed by CTD, the zinc-copper ratio imbalance — where zinc drops while copper rises — is a recognized contributor to mood disturbance, anxiety, and immune dysfunction that many women attribute to the hormonal contraceptive itself rather than to a correctable mineral deficit. Vitamin C and E depletions reflect increased antioxidant consumption from progesterone-mediated oxidative stress. Across 212 million rows in Kelda's database, levonorgestrel's 7-nutrient depletion profile matches the broader oral contraceptive class pattern but with higher sustained exposure from IUD delivery systems that maintain continuous progesterone receptor activation without the cyclical pill-free intervals that oral formulations provide.
Symptoms to Watch For
Levonorgestrel-induced nutrient depletions develop over months, creating a slowly evolving symptom pattern that many women and their prescribers attribute to hormonal side effects rather than correctable nutrient deficiencies. B6 depletion and zinc-copper imbalance are the most likely culprits behind mood changes, while magnesium loss drives the muscle cramps and sleep disturbance that worsen over time. The 7-nutrient depletion pattern means symptoms overlap and compound — fatigue from B12 and folate depletion layers on top of sleep disruption from magnesium loss, creating a cumulative burden that accelerates with years of continuous use. Testing and targeted supplementation can address each pathway independently.
What to Monitor
Request these at your next appointment. Check the ones you want to remember.
What vs Others
| Name | Depletions | Potency | Notes |
|---|---|---|---|
| LevonorgestrelThis drug | 7 nutrients | High | Synthetic progestin with 100% bioavailability, 40-hour half-life, available as IUD (Mirena/Kyleena), oral pill, and emergency contraception |
| Ethinyl Estradiol | 7 nutrients | High | Synthetic estrogen component of combined oral contraceptives, depletes same nutrients through estrogen-mediated pathways |
| Etonogestrel | 5 nutrients | Moderate | Implant-based progestin (Nexplanon), lower systemic levels than oral levonorgestrel, fewer documented depletions |
Levonorgestrel and ethinyl estradiol both deplete 7 nutrients, reflecting the broad metabolic impact of synthetic sex hormones on B-vitamin metabolism, mineral transport, and antioxidant systems. Etonogestrel in the Nexplanon implant depletes 5 nutrients at lower severity, likely because implant delivery produces lower peak systemic concentrations than oral dosing. According to 223 gene interactions cataloged in CTD for levonorgestrel, the progestin and estrogen depletion pathways are overlapping but not identical — combined pills deliver a double hit through both receptor systems simultaneously. IUD delivery (Mirena, Kyleena) produces primarily local progestin effects with lower systemic absorption, potentially reducing some depletion severity compared to oral formulations.
Food Sources for Depleted Nutrients
| Food | Amount per Serving |
|---|---|
| Chickpeas (canned) | 1.1mg per cup |
| Salmon (wild-caught) | 0.9mg per 3oz |
| Chicken breast | 0.5mg per 3oz |
| Banana | 0.4mg per medium fruit |
| Potatoes (baked, skin on) | 0.4mg per medium |
Source: USDA Food Composition Database (658,209 food nutrient entries)
FAQ
References
- [1]Comparative Toxicogenomics Database (CTD): 223 levonorgestrel gene interactions, 1,715 disease associations, 68 curated disease links (accessed April 2026)
- [2]ChEMBL Database: Levonorgestrel classified as progesterone receptor agonist, 100% oral bioavailability, 40-hour half-life, 98.25% protein binding (accessed April 2026)
- [3]PubMed: 1,527 indexed articles for levonorgestrel; 109 randomized controlled trials across 269,064 patients (accessed April 2026)
- [4]FAERS Database: Adverse event reporting for levonorgestrel including mood changes, bleeding irregularities, and metabolic effects (accessed April 2026)
- [5]Kelda Health Intelligence Platform: Cross-referenced analysis across 212 million rows integrating CTD, ChEMBL, FAERS, PharmGKB, and PubMed datasets (accessed April 2026)
- [6]PharmGKB Database: Pharmacogenomic annotations for levonorgestrel including CYP enzyme interactions and metabolic pathway data (accessed April 2026)
Check your medications
Check Free →